The Chemistry of Movement: Understanding Subtypes and Biology

Understanding why your child has Autosomal Recessive Dopa-Responsive Dystonia (AR DRD) requires looking at the brain’s internal chemical pathways. In a typical brain, several genes work together to produce the chemical messengers—neurotransmitters—that allow the brain to control movement, mood, and sleep ^[1][2].

When one of these genes has a mutation, the pathway breaks down. Depending on which gene is affected, the chemicals that are missing will vary, leading to the three main disorders commonly grouped under this umbrella ^[3][2].

The Three Main Subtypes

While all three conditions can result in a lack of dopamine (the primary messenger for movement), they happen for different biological reasons.

1. Tyrosine Hydroxylase (TH) Deficiency

In this subtype, the problem is at the first, rate-limiting step of dopamine production. The TH gene provides the instructions for the Tyrosine Hydroxylase enzyme, which takes an amino acid called tyrosine and turns it into L-Dopa, the direct building block of dopamine ^[3][4].

• What is missing: Primarily dopamine and its “descendants,” like norepinephrine (which helps with focus and blood pressure) ^[3].
• The hallmark: Because the block is only at the dopamine step, other systems—like those for serotonin or phenylalanine—usually work just fine ^[1].

2. PTPS (PTS) Deficiency

This subtype is a “cofactor deficiency.” To work correctly, many enzymes need a “helper” molecule called BH4 (tetrahydrobiopterin) ^[5]. The PTS gene is responsible for a step that synthesizes BH4 ^[2].

• What is missing: Because BH4 is a helper for many different processes, a lack of it causes a “domino effect” ^[6]. It disrupts:
  • Dopamine synthesis (movement)
  • Serotonin synthesis (mood and sleep)
  • Phenylalanine breakdown (the body’s ability to process a common protein component) ^[7][6].
• The hallmark: This subtype usually shows up on newborn screening because the child cannot break down phenylalanine, leading to high levels in the blood (hyperphenylalaninemia) ^[8][9].

3. SPR Deficiency

Like PTPS, SPR deficiency affects the helper molecule BH4 ^[10]. However, it affects the recycling and salvage of BH4, which leads to a unique biochemical profile.

• What is missing: Both dopamine and serotonin are significantly reduced ^[11][12].
• The hallmark: Unlike PTPS, children with SPR deficiency usually have normal phenylalanine levels in their blood ^[10][12]. This means the condition is almost never caught on a standard newborn screen ^[12].

The Biochemical Pathways

To see how these genes interact, it helps to look at the process as a sequence of events.

Why Newborn Screening Only Catches Some Cases

Most newborn screens are designed to look for Phenylketonuria (PKU), which is caused by high levels of phenylalanine in the blood ^[9].

Because PTPS deficiency blocks the breakdown of phenylalanine, it usually triggers a “red flag” on these screens ^[8]. (However, milder cases can still be missed, and a normal screen does not totally exclude it).

In contrast, TH deficiency and SPR deficiency do not typically cause high phenylalanine levels ^[1][12]. To the newborn screen, these children appear normal. This is why parents of children with these subtypes often face a much longer “diagnostic odyssey” before the true cause of their child’s symptoms is discovered ^[13]. Confirming these cases usually requires more specialized tests, such as checking neurotransmitter levels in the spinal fluid or performing detailed genetic sequencing ^[14][1].